Search - tctmd.com

Displaying 441 - 460 of 469

Sort: Relevancy | Date

News Daily News

PCI on the Rise Among the Elderly, Who Are Reaping Survival Gains

Caitlin E. Cox

April 23, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Shelley Wood

April 16, 2019

News Daily News

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Michael O'Riordan

April 15, 2019

News Daily News

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

Michael O'Riordan

April 11, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Conference News ACC 2019

Myocardial Injury Often Miscoded as Type 2 MI

L.A. McKeown

April 02, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News ACC 2019

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

Shelley Wood

March 19, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Shelley Wood

January 11, 2019

News Daily News

CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD

Caitlin E. Cox

December 14, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

Shelley Wood

October 31, 2018

Advertisement

PCI on the Rise Among the Elderly, Who Are Reaping Survival Gains

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Myocardial Injury Often Miscoded as Type 2 MI

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

TCTMD’s Top 10 Most Popular Stories for October 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content